ARMP
Armata Pharmaceuticals Inc
3.50$
+6.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +108.9% | +11.8% | +1.4% | +4.0% | +247.3% | -17.5% | +4.9% | -23.7% | +9.0% | +36.3% | +15.5% | |
| – | -75.1% | +313.0% | -64.9% | -31.7% | +793.5% | -18.6% | -17.1% | +7.7% | -69.8% | +208.4% | -9.8% | |
| – | – | – | – | +1,676.1% | -9.0% | -22.5% | -7.0% | +14.2% | – | – | – | |
| – | – | – | -168.2% | – | -734.5% | – | – | – | -2,297.3% | – | – | |
| – | -82.5% | +32.9% | -79.2% | -24.1% | +197.7% | +529.0% | +58.3% | +69.6% | +268.3% | -76.9% | -71.2% | |
| – | -82.5% | +32.9% | -79.2% | -24.1% | – | -128.6% | +58.3% | +69.6% | +267.9% | -76.9% | -71.2% | |
| – | – | – | -100.0% | – | – | – | – | – | – | – | – | |
| – | – | -101.4% | – | +31.3% | -19.9% | +131.2% | +16.8% | +65.3% | -100.1% | – | – | |
| – | – | – | – | +0.0% | +0.0% | +0.0% | -100.0% | – | – | -35.4% | -28.3% | |
| – | – | -43.6% | +20.3% | +43.6% | -27.9% | +158.6% | +9.9% | +72.5% | +22.7% | -35.2% | -26.7% | |
| – | – | -231.2% | – | – | -223.3% | – | -84.5% | +614.2% | -134.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.